ID24506A - Turunan-turunan 1,2,4-triazolo [4,3-b] pirido [3,2-d]-piridazina dan komposisi-komposisi farmasi yang mengandung senyawa tersebut - Google Patents

Turunan-turunan 1,2,4-triazolo [4,3-b] pirido [3,2-d]-piridazina dan komposisi-komposisi farmasi yang mengandung senyawa tersebut

Info

Publication number
ID24506A
ID24506A IDW20000180A ID20000180A ID24506A ID 24506 A ID24506 A ID 24506A ID W20000180 A IDW20000180 A ID W20000180A ID 20000180 A ID20000180 A ID 20000180A ID 24506 A ID24506 A ID 24506A
Authority
ID
Indonesia
Prior art keywords
piridazine
triazolo
pyrido
compound
composition containing
Prior art date
Application number
IDW20000180A
Other languages
English (en)
Indonesian (id)
Inventor
Ferrer Jordi Gracia
Original Assignee
Almirall Prodesfarma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma Sa filed Critical Almirall Prodesfarma Sa
Publication of ID24506A publication Critical patent/ID24506A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW20000180A 1997-07-29 1998-07-13 Turunan-turunan 1,2,4-triazolo [4,3-b] pirido [3,2-d]-piridazina dan komposisi-komposisi farmasi yang mengandung senyawa tersebut ID24506A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701670A ES2137113B1 (es) 1997-07-29 1997-07-29 Nuevos derivados de triazolo-piridazinas heterociclicos.

Publications (1)

Publication Number Publication Date
ID24506A true ID24506A (id) 2000-07-20

Family

ID=8300216

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000180A ID24506A (id) 1997-07-29 1998-07-13 Turunan-turunan 1,2,4-triazolo [4,3-b] pirido [3,2-d]-piridazina dan komposisi-komposisi farmasi yang mengandung senyawa tersebut

Country Status (36)

Country Link
US (2) US6407108B1 (sl)
EP (1) EP1001955B1 (sl)
JP (1) JP4320118B2 (sl)
KR (1) KR20010022353A (sl)
CN (1) CN1135231C (sl)
AR (1) AR015927A1 (sl)
AT (1) ATE207069T1 (sl)
AU (1) AU737709B2 (sl)
BG (1) BG64448B1 (sl)
BR (1) BR9810829B1 (sl)
CA (1) CA2298935A1 (sl)
CO (1) CO4970780A1 (sl)
CZ (1) CZ290208B6 (sl)
DE (1) DE69802100T2 (sl)
DK (1) DK1001955T3 (sl)
EE (1) EE04313B1 (sl)
EG (1) EG24041A (sl)
ES (2) ES2137113B1 (sl)
HK (1) HK1024914A1 (sl)
HU (1) HUP0004708A3 (sl)
ID (1) ID24506A (sl)
IL (1) IL134081A (sl)
MY (1) MY118796A (sl)
NO (1) NO315118B1 (sl)
NZ (1) NZ502356A (sl)
PE (1) PE111099A1 (sl)
PL (1) PL191031B1 (sl)
PT (1) PT1001955E (sl)
RU (1) RU2202552C2 (sl)
SI (1) SI1001955T1 (sl)
SK (1) SK284046B6 (sl)
TR (1) TR200000243T2 (sl)
TW (1) TW542837B (sl)
UA (1) UA60339C2 (sl)
WO (1) WO1999006404A1 (sl)
ZA (1) ZA986248B (sl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792938B1 (fr) 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
PT1212089E (pt) 1999-08-21 2006-08-31 Altana Pharma Ag Combinacao sinergica de roflumilast e salmeterol
WO2002080974A1 (fr) * 2001-04-04 2002-10-17 Sankyo Company, Limited Utilisation medicale d'inhibiteur de production de cytokine
HU229442B1 (hu) * 2001-09-19 2013-12-30 Takeda Gmbh Nem-szteroid gyulladásgátlók és PDE4 inhibitorok kombinációi és alkalmazásuk
FR2832711B1 (fr) * 2001-11-26 2004-01-30 Warner Lambert Co Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
CN100572381C (zh) * 2002-11-06 2009-12-23 Aska制药株式会社 吡唑并二氮杂萘衍生物
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
RU2246496C1 (ru) * 2003-09-12 2005-02-20 Тец Виктор Вениаминович Вещество с противовирусной и антибактериальной активностью на основе производных 2,8-дитиоксо-1h-пирано[2,3-d, 6,5-d`] дипиримидина и их 10-аза-аналогов
ES2251866B1 (es) 2004-06-18 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
CA2610888C (en) * 2005-06-10 2011-02-08 Merck & Co., Inc. Inhibitors of akt activity
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2622605A1 (en) 2005-09-15 2007-03-22 Aska Pharmaceutical Co., Ltd. Heterocycle compound, and production process and application thereof
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2660836A1 (en) 2006-08-07 2008-02-21 Incyte Corporation Triazolotriazines as kinase inhibitors
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EA026126B1 (ru) 2006-11-22 2017-03-31 Инсайт Холдингс Корпорейшн Имидазотриазины и имидазопиримидины в качестве ингибиторов киназы
WO2009089027A1 (en) * 2008-01-09 2009-07-16 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Service, National Institutes Of Health Phosphodiesterase inhibitors
WO2009143211A2 (en) 2008-05-21 2009-11-26 Incyte Corporation Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2226323A1 (en) 2009-02-27 2010-09-08 Almirall, S.A. New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
SG182297A1 (en) 2009-12-31 2012-08-30 Ct Nac Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
BR112012019302B1 (pt) 2010-02-03 2022-06-21 Incyte Holdings Corporation Imidazo[1,2-b] [1,2,4]triazinas como inibidores de c-met, composição que as compreende e métodos in vitro de inibir a atividade de c-met cinase, de inibir a via de sinalização da hgf/c-met cinase em uma célula e de inibir a atividade proliferativa de uma célula
EP2380890A1 (en) 2010-04-23 2011-10-26 Almirall, S.A. New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
EP2394998A1 (en) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
WO2012098387A1 (en) 2011-01-18 2012-07-26 Centro Nacional De Investigaciones Oncológicas (Cnio) 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
WO2013005041A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) Tricyclic heterocyclic compounds as kinase inhibitors
WO2013004984A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncologicas (Cnio) Tricyclic compounds for use as kinase inhibitors
WO2013005057A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) New compounds
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3122670A1 (de) 1981-06-06 1982-12-23 Dr. Karl Thomae Gmbh, 7950 Biberach "neue 1,4,9,10-tetrahydro-pyrazolo(4,3-e) pyrido(3,2-b)(1,4)diazepin-10-one, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen wirkstoffen"
PH21834A (en) * 1982-01-18 1988-03-17 Lepetit Spa New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
JP3120857B2 (ja) * 1990-02-19 2000-12-25 中外製薬株式会社 新規な縮合複素環化合物とこれを用いた抗喘息剤
DK0612321T3 (da) * 1991-10-09 1999-12-13 Syntex Inc Pyridopyridazinon- og pyridazinthionforbindelser med PDE IV inhiberende aktivitet
GB9514465D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds

Also Published As

Publication number Publication date
KR20010022353A (ko) 2001-03-15
BR9810829A (pt) 2000-07-25
US6407108B1 (en) 2002-06-18
DK1001955T3 (da) 2001-11-19
EE04313B1 (et) 2004-06-15
PE111099A1 (es) 1999-11-18
JP4320118B2 (ja) 2009-08-26
AU8861298A (en) 1999-02-22
BR9810829B1 (pt) 2009-08-11
EP1001955B1 (en) 2001-10-17
WO1999006404A1 (en) 1999-02-11
ZA986248B (en) 1999-02-05
CZ2000333A3 (cs) 2000-05-17
NO315118B1 (no) 2003-07-14
US20020183326A1 (en) 2002-12-05
SK862000A3 (en) 2000-07-11
IL134081A0 (en) 2001-04-30
DE69802100D1 (de) 2001-11-22
BG104112A (en) 2001-01-31
CZ290208B6 (cs) 2002-06-12
IL134081A (en) 2004-02-08
DE69802100T2 (de) 2002-03-14
EP1001955A1 (en) 2000-05-24
NZ502356A (en) 2001-03-30
BG64448B1 (en) 2005-02-28
CN1266434A (zh) 2000-09-13
NO20000394D0 (no) 2000-01-26
EE200000052A (et) 2000-10-16
AR015927A1 (es) 2001-05-30
NO20000394L (no) 2000-03-27
HK1024914A1 (en) 2000-10-27
ES2137113B1 (es) 2000-09-16
HUP0004708A3 (en) 2002-11-28
PL338214A1 (en) 2000-10-09
PT1001955E (pt) 2002-02-28
CA2298935A1 (en) 1999-02-11
SI1001955T1 (sl) 2002-02-28
UA60339C2 (uk) 2003-10-15
CN1135231C (zh) 2004-01-21
CO4970780A1 (es) 2000-11-07
PL191031B1 (pl) 2006-03-31
TR200000243T2 (tr) 2000-07-21
RU2202552C2 (ru) 2003-04-20
ATE207069T1 (de) 2001-11-15
ES2162466T3 (es) 2001-12-16
HUP0004708A2 (hu) 2001-07-30
AU737709B2 (en) 2001-08-30
TW542837B (en) 2003-07-21
JP2001512121A (ja) 2001-08-21
SK284046B6 (sk) 2004-08-03
MY118796A (en) 2005-01-31
ES2137113A1 (es) 1999-12-01
EG24041A (en) 2008-04-03

Similar Documents

Publication Publication Date Title
ID24506A (id) Turunan-turunan 1,2,4-triazolo [4,3-b] pirido [3,2-d]-piridazina dan komposisi-komposisi farmasi yang mengandung senyawa tersebut
ID29514A (id) 2-ARIL-3-(HETEROARIL)-IMIDAZO [1,2-a]PIRIMIDIN TERSUBSTITUSI, DAN METODE-METODE DAN KOMPOSISI-KOMPOSISI FARMASI YANG TERKAIT
IS2461B (is) Pýrróló [2,3-dl]pýrimídín efnasambönd
HUP0203503A3 (en) Pyrrolo[2,3-d]pirimidine compounds, pharmaceutical compositions containing them and their use
NO974595D0 (no) Imidazo£1,2-a|pyridin-derivater
HK1045510A1 (en) Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
ZA971887B (en) Pyrimido[5,4-d]pyrimidines pharmaceuticals containing them their use and processes for the preparation thereof
ID21824A (id) TURUNAN-TURUNAN 5H-TIAZOLO [3,2-a] PIRIMIDINA
ID23439A (id) Turunan-turunan 3-piperidil-4-oksokuinazolin dan komposisi-komposisi farmasi yang sama
ZA971886B (en) Pyrimido[5,4-d]pyrimidines pharmaceuticals containing them their use and processes for the preparation thereof
IL117824A0 (en) Use of imidazo [1,2-alpha] pyridine-3-acetamide derivatives
HUP0100328A3 (en) Novel triazolo(4,5-d)pyrimidine compounds, and pharmaceutical compositions containing the compounds
HUP0104164A3 (en) Imidazo[4,5-c]-pyridine-4-one derivatives with factor xa inhibiting effect, pharmaceutical compositions containing the same and process for their preparation
PL349364A1 (en) Use of pyridazino[4,5-b
EE200100377A (et) Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena
PL349341A1 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives
HK1026429A1 (en) New formulation
NO962320D0 (no) Tricykliske 5,6-dihydro-9H-pyrazolo [3,4cÅ-1,2,4-triazolo [4,3-aÅ pyridiner
AU2253297A (en) Imidazo{1,2-a}pyridine c-nucleosides as antiviral agents
IL135982A0 (en) Fungicidal combinations comprising thieno[2,3-d]pyrimidin-4-one
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
ZA984561B (en) 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo[3,2--D]pyrimidin-4-ones
AU699057B2 (en) Chemical composition
ID24045A (id) Turunan 3-tersubstitusi pirido [3',4':4,5] tieno [2,3-d] pirimidin, pembuatan dan penggunaannya
AU8863098A (en) Chemical composition